Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 372

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 372
---
 the Alternative Standards. If the Company continues to not be in compliance or if the Company fails to meet other Nasdaq continuing listing requirements, the Company’s common stock may be subject to delisting, and the Company may become subject to delisting proceedings. As requested by Nasdaq, the Company subsequently submitted a plan to regain compliance to Nasdaq, or the Compliance Plan (see Note 23, Subsequent Events). 2. Summary of Significant Accounting Policies Reverse Stock Split At a special meeting of the Company’s stockholders held on April 1, 2025 (the “Special Meeting”), the Company’s stockholders approved (i) an amendment to the Company’s amended and restated certificate of incorporation to effect a reverse stock split of the Company’s issued common stock at a ratio of 1:3(the “2025 Reverse Stock Split”) and (ii) an amendment to the Company’s amended and restated certificate to increase the authorized number of shares of the Company’s common stock from 16,666,667shares to 150,000,000shares. On April 15, 2025, the Company amended its amended and restated certificate of incorporation to (i) effect the 2025 Reverse Stock Split, effective as of 4:01 pm Eastern Time on April 15, 2025, and (ii) to increase the authorized number of shares of the Company’s common stock from 16,666,667shares to 150,000,000shares, effective as of 4:02 pm Eastern Time on April 15, 2025 (see Note 23, Subsequent Events). As a result of the 2025 Reverse Stock Split, every threeshares of the Company’s common stock held by a stockholder immediately prior to the 2025 Reverse Stock Split were combined and reclassified into one share of the Company’s common stock. As such, immediately following the 2025 Reverse Stock Split, there were approximately 1.5million shares of the Company’s common stock outstanding. Nofractional shares were issued in connection with the 2025 Reverse Stock Split. Stockholders who would have otherwise held a fraction of a share of common stock of the Company received a cash payment in lieu thereof. In addition, proportionate adjustments were made to the number of shares underlying, and the exercise or conversion prices of, the Company’s outstanding stock options, and to the number of shares of common stock issuable under the Company’s equity incentive plans. Accordingly, all share and per share